Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks |
| |
| Authors: | Sax Paul E,DeJesus Edwin,Mills Anthony,Zolopa Andrew,Cohen Calvin,Wohl David,Gallant Joel E,Liu Hui C,Zhong Lijie,Yale Kitty,White Kirsten,Kearney Brian P,Szwarcberg Javier,Quirk Erin,Cheng Andrew K GS-US-- study team |
| |
| Affiliation: | Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. psax@partners.org |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
